Founder and Managing Director of Pharmsite, which represents select overseas eClinical solutions in Australia and New Zealand. Senior Executive with regional responsibility for business development and support of eClinical solutions. Former Regional General Manager and Director of Australian subsidiaries of leading US eClinical vendors. Actively engaged in industry groups with a vision to improve the conduct of clinical trials and coordination and curation of health informatics. Conference Chair and speaker at local and overseas industry forums. Currently Co-Convenor of the ARCS AsiaPac Interest Area. Chair of the NSW Branch Committee of AIDH (Australian Institute of Digital Health).

REGIS Program Manager, Kylie Becker, has been responsible for driving the strategic development of REGIS since its inception in 2017. She has led numerous functional enhancement rounds for REGIS, establishing expert user groups and broad stakeholder consultation initiatives, which have resulted in major improvements to user interface and system intuitiveness, including a single NSW Progress Report Form, improved Head of Department sign off and intuitive dashboards to support Research Offices manage applications. Kylie is currently preparing REGIS and NSW Health for the eventual migration to the National One Stop Shop. Kylie has a strong ethos in customer service and is committed to ensuring that NSW Health and all its stakeholders are prepared and supported for this large change. Prior to joining the REGIS Team, Kylie was the Research Governance Officer for over 5 years with the Kolling Research Office at Northern Sydney Local Health District, leading researcher-friendly change management and streamlining processes. Kylie also has extensive experience providing Ethics Support for both Human and Animal Ethics Committees at Northern Sydney LHD and has coordinated various health and education programs for health services both locally and interstate.

Principal Project Officer within NSW Health, Office for Health and Medical Research. Currently leading implementation of a clinical trial management system across all NSW public hospitals. Extensive experience in clinical trials for rare and high-risk paediatric cancers, immunotherapy, biologics and novel agents. Experienced in FIH and early phase trials as well as Phase II and III trials. Experience working with investigator initiated collaborative studies as well as pharmaceutical/industry managed clinical studies. Experience working internationally with sites based in North America and Europe. Extensive experience in clinical research including knowledge of GCP-ICH Guidelines, TGA Guidelines and other applicable regulatory requirements.

Associate Professor Tam Nguyen has close to 25 years of working in the healthcare, health & medical research sector including tertiary teaching hospitals and research institute across Australia. Tam is the Deputy Director of Research at St Vincent’s Hospital Melbourne, one of the largest tertiary teaching and research hospitals in Melbourne - responsible for the organisation’s research strategy, research ethics and governance, clinical trials, research innovation and development. SVHM is part of St Vincent’s Health Australia Network – a $3B health care network and second largest healthcare provider in Australia. Tam works closely with Federal and State departments to promote Australia as the destination to conduct clinical trials, often hosting inbound trade missions and attending BIO, BioASIA Taiwan and other Austrade outbound trade missions. Tam is active with a number peak bodies including AusBiotech, ARCS and the Society of Clinical Research Sites (SCRS) and is the current chair of the SCRS ANZ. He is a regular invited speaker on a broad range of topics on clinical trials and healthcare innovation. He chairs and moderates at numerous national and international conferences. Tam is the co-editor of the recently published book AI in Medicine: Applications, Limitations and Future Directions (Springer Nature)